What is the equity of Insulet this year?
Insulet has equity of 1.21 B USD this year.
Insulet Equity 2025
Insulet Equity
1.21 B USD
Ticker
PODD
ISIN
US45784P1012
WKN
A0MQX8
In 2025, Insulet's equity was 1.21 B USD, a 65.36% increase from the 732.7 M USD equity in the previous year.
Insulet Aktienanalyse
What does Insulet do?
Insulet Corp is an American company that was founded in 2000 and is headquartered in Acton, Massachusetts. Its goal is to improve the quality of life for people with diabetes by developing innovative products that make living with this chronic disease easier. Insulet Corp is known for its product "OmniPod." The OmniPod is a wireless, portable disposable insulin pump system that offers an alternative option to traditional pumping and insulin delivery systems. The OmniPod system consists of two small devices: a pod worn on the skin and a PDM (Personal Diabetes Manager) that regulates insulin delivery. The pod contains an insulin reservoir that communicates wirelessly with the PDM. The insulin dose is administered directly into the body without needles or tubes. Insulet Corp is also introducing the "OmniPod DASH System." This new system combines the proven design of the OmniPod pod with a new color touchscreen handheld device that allows for even easier operation. The DASH system also offers the ability to control insulin dosing from a smartphone, which can be taken with diabetics wherever they go. The success of the OmniPod system has made Insulet Corp a leading company in the diabetes industry. The company has also developed and introduced products and services in other areas of diabetes treatment. Insulet Corp has developed another product called "Amigo." This product is a personalized travel and training program for people who require insulin. Amigo offers specialized and personalized training to support diabetics in managing complex situations. It also offers diet and exercise plans to make living with diabetes easier. Insulet Corp has also developed a software called "OmniPod Horizon." This software is a closed-loop system that automatically adjusts insulin dosing to keep blood sugar levels within the target range. The system is currently in the development phase and is expected to be released in 2020. Insulet Corp has also developed a program called the "OmniPod Partner Program," which targets doctors and pharmacists. The program provides training and educational materials for healthcare providers to help them better treat and manage their patients. Since 2009, Insulet Corp has been listed on the NASDAQ stock exchange and has continuously evolved since then. The company currently has over 1500 employees and operates in North America, Europe, and the Middle East. Insulet Corp is a company focused on the development of innovative, life-changing products and services. It is expected to continue to play a significant role in improving the quality of life for people with diabetes in the future. Insulet ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Insulet's Equity
Insulet's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Insulet's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Insulet's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Insulet's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Insulet’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Insulet stock
What was the equity of Insulet compared to the previous year?
The equity of Insulet has increased/decreased by 65.36% increased compared to the previous year.
What impact does a high equity have on investors of Insulet?
A high equity is advantageous for investors of Insulet as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Insulet?
A low equity can be a risk for investors of Insulet, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Insulet affect the company?
An increase in equity of Insulet can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Insulet affect the company?
A reduction in equity of Insulet can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Insulet?
Some factors that can affect the equity of Insulet include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Insulet so important for investors?
The equity of Insulet is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Insulet take to change the equity?
To change equity, Insulet can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Insulet pay?
Over the past 12 months, Insulet paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Insulet is expected to pay a dividend of 0 USD.
What is the dividend yield of Insulet?
The current dividend yield of Insulet is .
When does Insulet pay dividends?
Insulet pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Insulet?
Insulet paid dividends every year for the past 0 years.
What is the dividend of Insulet?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Insulet located?
Insulet is assigned to the 'Health' sector.
Wann musste ich die Aktien von Insulet kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Insulet from 10/7/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/7/2025.
When did Insulet pay the last dividend?
The last dividend was paid out on 10/7/2025.
What was the dividend of Insulet in the year 2024?
In the year 2024, Insulet distributed 0 USD as dividends.
In which currency does Insulet pay out the dividend?
The dividends of Insulet are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Insulet stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Insulet
Our stock analysis for Insulet Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Insulet Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
